Solid Biosciences (SLDB) Other financing activities (2018 - 2026)

Solid Biosciences has reported Other financing activities for 6 years, with the latest figure at $18000.0 in Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24000.0 (down 92.16% YoY) and the FY2025 annual result came in at $6000.0, down 98.69% from the prior year.
• Other financing activities improved to $18000.0 in Q1 2026 per SLDB's latest filing, from $6000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $278000.0 in Q3 2024 and troughed at $6000.0 in Q2 2025.
• A 4-year average of $71857.1 and a median of $19000.0 in 2024 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2025: Other financing activities decreased 24.14% in 2022, then plunged 33.33% in 2025.
• Over 4 years, Other financing activities stood at $22000.0 in 2022, then decreased by 13.64% to $19000.0 in 2024, then tumbled by 68.42% to $6000.0 in 2025, then surged by 200.0% to $18000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $18000.0, $6000.0, and $19000.0 for Q1 2026, Q2 2025, and Q4 2024 respectively.